133 related articles for article (PubMed ID: 21119893)
1. Transcription Factor CHF1/Hey2 Regulates Specific Pathways in Serum Stimulated Primary Cardiac Myocytes: Implications for Cardiac Hypertrophy.
Yu M; Xiang F; Beyer RP; Farin FM; Bammler TK; Chin MT
Curr Genomics; 2010 Jun; 11(4):287-96. PubMed ID: 21119893
[TBL] [Abstract][Full Text] [Related]
2. CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways.
Yu M; Liu Y; Xiang F; Li Y; Cullen D; Liao R; Beyer RP; Bammler TK; Chin MT
OMICS; 2009 Dec; 13(6):501-11. PubMed ID: 20001863
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
[TBL] [Abstract][Full Text] [Related]
4. Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias.
Hartman ME; Liu Y; Zhu WZ; Chien WM; Weldy CS; Fishman GI; Laflamme MA; Chin MT
FASEB J; 2014 Jul; 28(7):3007-15. PubMed ID: 24687990
[TBL] [Abstract][Full Text] [Related]
5. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload.
Liu Y; Yu M; Wu L; Chin MT
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2082-92. PubMed ID: 20382855
[TBL] [Abstract][Full Text] [Related]
6. Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes.
Wu L; Chien WM; Hartman ME; Moussavi-Harami F; Liu Y; Chin MT
Biochem Biophys Res Commun; 2011 Dec; 415(4):662-8. PubMed ID: 22079635
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor CHF1/Hey2 regulates coronary vascular maturation.
Watanabe T; Koibuchi N; Chin MT
Mech Dev; 2010; 127(9-12):418-27. PubMed ID: 20619341
[TBL] [Abstract][Full Text] [Related]
8. CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6.
Shirvani S; Xiang F; Koibuchi N; Chin MT
Biochem Biophys Res Commun; 2006 Jan; 339(1):151-6. PubMed ID: 16293227
[TBL] [Abstract][Full Text] [Related]
9. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression.
Koibuchi N; Chin MT
Circ Res; 2007 Mar; 100(6):850-5. PubMed ID: 17332425
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor CHF1/Hey2 regulates the global transcriptional response to platelet-derived growth factor in vascular smooth muscle cells.
Shirvani SM; Mookanamparambil L; Ramoni MF; Chin MT
Physiol Genomics; 2007 Jun; 30(1):61-8. PubMed ID: 17327490
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation.
Sakata Y; Koibuchi N; Xiang F; Youngblood JM; Kamei CN; Chin MT
J Mol Cell Cardiol; 2006 Feb; 40(2):267-73. PubMed ID: 16242143
[TBL] [Abstract][Full Text] [Related]
13. Expression of Hey2 transcription factor in the early embryonic ventricles is controlled through a distal enhancer by Tbx20 and Gata transcription factors.
Ihara D; Watanabe Y; Seya D; Arai Y; Isomoto Y; Nakano A; Kubo A; Ogura T; Kawamura T; Nakagawa O
Dev Biol; 2020 May; 461(2):124-131. PubMed ID: 32035085
[TBL] [Abstract][Full Text] [Related]
14. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.
Fischer A; Klattig J; Kneitz B; Diez H; Maier M; Holtmann B; Englert C; Gessler M
Mol Cell Biol; 2005 Oct; 25(20):8960-70. PubMed ID: 16199874
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy.
Vara D; Bicknell KA; Coxon CH; Brooks G
J Biol Chem; 2003 Jun; 278(24):21388-94. PubMed ID: 12682052
[TBL] [Abstract][Full Text] [Related]
16. Notch signaling regulates Hey2 expression in a spatiotemporal dependent manner during cardiac morphogenesis and trabecular specification.
Miao L; Li J; Li J; Tian X; Lu Y; Hu S; Shieh D; Kanai R; Zhou BY; Zhou B; Liu J; Firulli AB; Martin JF; Singer H; Zhou B; Xin H; Wu M
Sci Rep; 2018 Feb; 8(1):2678. PubMed ID: 29422515
[TBL] [Abstract][Full Text] [Related]
17. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
18. Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy.
Chen H; Huang XN; Stewart AF; Sepulveda JL
Physiol Genomics; 2004 Aug; 18(3):273-83. PubMed ID: 15306692
[TBL] [Abstract][Full Text] [Related]
19. Transfection by eukaryotic expression vector pcDNA3-HERG inhibits the cultured neonatal rabbit ventricular myocyte hypertrophy induced by phenylephrine.
Zhao Y; Xu Y; Cui C; Li Y; Zeng Y
Cardiovasc Pathol; 2012; 21(4):339-45. PubMed ID: 22100990
[TBL] [Abstract][Full Text] [Related]
20. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte.
Tanaka K; Honda M; Takabatake T
J Am Coll Cardiol; 2001 Feb; 37(2):676-85. PubMed ID: 11216996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
